Atrial Fibrillation and Obesity Not Just a Coincidence∗ by Hatem, Stéphane N.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 6 , N O . 1 , 2 0 1 5
ª 2 0 1 5 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j a c c . 2 0 1 5 . 0 4 . 0 5 7EDITORIAL COMMENTAtrial Fibrillation and Obesity
Not Just a Coincidence*Stéphane N. Hatem, MD, PHDSEE PAGE 1T he risk of developing atrial ﬁbrillation (AF) isincreased in obese patients. This has beenwell established by several epidemiological
studies. For instance, the long-term follow-up of the
Framingham Heart Study reported that every unit
increase in body mass index (BMI) raises AF risk by
4% (1–5). At ﬁrst glance, this epidemiological observa-
tion could be explained by the fact that obesity is
often associated with enlarged left atria, ventricular
dysfunction, and hypertension, all of which can
generate a susceptible AF substrate (6). Sleep apnea
and autonomic dysfunction—often present in obese
patients—could also contribute to increased AF risk.
However, the relationship between obesity and AF
may not only be due to the coincidental accumulation
of common comorbidity factors between the 2 clinical
entities, but rather to the speciﬁc effects of obesity on
the structural and functional properties of the atrial
myocardium (7). Obesity is a systemic disease char-
acterized by low-grade inﬂammation, increased
renin-angiotensin-aldosterone system and endothe-
lin pathway activities, as well as higher levels of
transforming growth factor (TGF)-b1. These factors
are coupled to signaling pathways involved in hyper-
trophy and ﬁbrosis of the myocardium, and therefore
support the possibility that obesity could be another
distinct risk factor for AF.
In this issue of the Journal, the article by Mahajan
et al. (8) explores the nature of the link between*Editorials published in the Journal of the American College of Cardiology
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a high-calorie diet for 72 weeks showed a typical
AF substrate, with left atrial dilation, conduction
abnormalities, fractioned electrocardiograms, and an
abnormal vulnerability to AF. Diffuse interstitialﬁbrosis of the atrial myocardium is observed at the
tissue level, probably explained by the 5-fold in-
crease in local TGF-b1 expression. But the most exit-
ing ﬁnding arising from this study is that obesity is
associated with a distinct AF substrate, as a result of
fatty inﬁltration of the abundant adipose tissue
contiguous to epicardial adipose tissue into the atrial
myocardium. This fatty inﬁltration predominates in
the posterior wall of the left atria, at the junction of
the pulmonary veins. Using endocardial mapping, the
authors found that the posterior wall of the fatty
inﬁltrated myocardium generated low and heteroge-
neous voltage. It is possible that the inﬁltration of
adipose tissue alters the functional organization of
the atrial myocardium, resulting in local conduc-
tion block and depressed excitability, as has been
described for the ventricular myocardium (9). In
addition, adipose tissue produces a myriad of in-
ﬂammatory cytokines, chemokines, adipokines, and
growth factors, which can freely diffuse into the
adjacent myocardium and modify its structural and
functional properties (10–12). For instance, epicardial
adipose tissue secretes activin A, a member of the
TGF family, which has a ﬁbrotic effect on the atrial
myocardium (12).
What is the origin of this fatty inﬁltration? It could
be caused by a nonspeciﬁc general process of ectopic
fat accumulation, as overwhelmed subcutaneous
adipose tissue attempts to clear excess triglycerides
in obese patients (13). It could also result from the
activation of local and speciﬁc mechanisms in
response to various myocardial hemodynamic or
metabolic stresses. In support of this assumption,
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13atrial fat accumulation is now recognized as a pre-
dictor of the risk and severity of AF, independent of
obesity, suggesting crosstalk between the atrial myo-
cardium and adipose tissue (14). For instance, both
rapid atrial pacing and AF induce the expression
of several adipocyte-related genes that can regulate
adipose tissue accumulation (15).
The study by Mahajan et al. (8) has 2 potential
clinical implications. First, advances in cardiac im-
agery should lead to an improved ability to visualize
myocardial fat depositions, and consequently aid in
the detection of AF substrates in both obese patients
and those with metabolic syndromes. Second, weight
loss could have a beneﬁcial effect on atrial remod-
eling and AF substrate formation. Interestingly,5 months after bariatric surgery, epicardial fat volume
diminishes, the left atrium reduces in size, and ven-
tricular diastolic ﬁlling properties are improved (16).
Taken together, the observation that obesity and ad-
ipose tissue dysregulation can have a direct impact on
the structure and physiological properties of the atrial
myocardium justiﬁes study into the effects of up-
stream and personalized therapies on AF substrate
progression and arrhythmia occurrence in overweight
patients.
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